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Despite the central role that antibodies play in the adaptive immune system and in biotechnol-
ogy, much remains unknown about the quantitative relationship between an antibody’s amino acid
sequence and its antigen binding affinity. Here we describe a new experimental approach, called Tite-
Seq, that is capable of measuring binding titration curves and corresponding affinities for thousands
of variant antibodies in parallel. The measurement of titration curves eliminates the confounding
effects of antibody expression and stability that arise in standard deep mutational scanning assays.
We demonstrate Tite-Seq on the CDR1H and CDR3H regions of a well-studied scFv antibody. Our
data shed light on the structural basis for antigen binding affinity and suggests a role for secondary
CDR loops in establishing antibody stability. Tite-Seq fills a large gap in the ability to measure crit-
ical aspects of the adaptive immune system, and can be readily used for studying sequence-affinity
landscapes in other protein systems.
I. INTRODUCTION
During an infection, the immune system must rec-
ognize and neutralize invading pathogens. B-cells con-
tribute to immune defense by producing antibodies, pro-
teins that bind specifically to foreign antigens. The as-
tonishing capability of antibodies to recognize virtually
any foreign molecule has been repurposed by scientists in
wide variety of experimental techniques (immunofluores-
cence, western blots, ELISA, ChIP-Seq, etc.). Antibody-
based therapeutic drugs have also been developed for
treating many different diseases, including cancer [1].
Much is known about the qualitative mechanisms of
antibody generation and function [2]. The antigenic
specificity of antibodies in humans, mice, and most jawed
vertebrates is primarily governed by six complementar-
ity determining regions (CDRs), each roughly 10 amino
acids (aa) long. Three CDRs (denoted CDR1H, CDR2H,
and CDR3H) are located on the antibody heavy chain,
and three are on the light chain. During B-cell differ-
entiation, these six sequences are randomized through
V(D)J recombination, then selected for functionality as
well as against the ability to recognize host antigens.
Upon participation in an immune response, CDR re-
gions can further undergo somatic hypermutation and
selection, yielding higher-affinity antibodies for specific
antigens. Among the CDRs, CDR3H is the most highly
variable and typically contributes the most to antigen
specificity; less clear are the functional roles of the other
CDRs, which often do not interact with the target anti-
gen directly.
Many high-throughput techniques, including phage
display [3–5], ribosome display [6], yeast display [7, 8],
and mammalian cell display [9], have been developed
for optimizing antibodies ex vivo. Advances in DNA se-
quencing technology have also made it possible to effec-
tively monitor both antibody and T-cell receptor diver-
sity within immune repertoires, e.g. in healthy individ-
uals [10–21], in specific tissues [22], in individuals with
diseases [23] or following vaccination [24–28]. Yet many
questions remain about basic aspects of the quantita-
tive relationship between antibody sequence and antigen
binding affinity. How many different antibodies will bind
a given antigen with specified affinity? How large of a
role do epistatic interactions between amino acid posi-
tions within the CDRs have on antigen binding affinity?
How is this sequence-affinity landscape navigated by the
V(D)J recombination process, or by somatic hypermuta-
tion? Answering these and related questions is likely to
prove critical for developing a systems-level understand-
ing of the adaptive immune system, as well as for using
antibody repertoire sequencing to diagnose and monitor
disease.
Recently developed “deep mutational scanning”
(DMS) assays [29] provide one potential method for mea-
suring binding affinities with high enough throughput to
effectively explore antibody sequence-affinity landscapes.
In DMS experiments, one begins with a library of vari-
ants of a specific protein. Proteins that have high levels
of a particular activity of interest are then enriched via
one or more rounds of selection, which can be carried out
in a variety of ways. The set of enriched sequences is then
compared to the initial library, and protein sequences (or
mutations within these sequences) are scored according
to how much this enrichment procedure increases their
prevalence.
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2Multiple DMS assays have been described for investi-
gating protein-ligand binding affinity. But no DMS as-
say has yet been shown to provide quantitative binding
affinity measurements, i.e., dissociation constants in mo-
lar units. For example, one of the first DMS experiments
[30] used phage display technology to measure how muta-
tions in a WW domain affect the affinity of this domain
for its peptide ligand. These data were sufficient to com-
pute enrichment ratios and corresponding sequence logos,
but they did not yield quantitative affinities. Analogous
experiments have since been performed on antibodies us-
ing yeast display [31, 32] and mammalian cell display [9],
but these approaches do not provide quantitative affin-
ity values either. SORTCERY [31, 33], a DMS assay
that combines yeast display and quantitative modeling,
has been shown to provide approximate rank-order val-
ues for the affinity of a specific protein for short unstruc-
tured peptides of varying sequence. Determining quanti-
tative affinities from SORTCERY data, however, requires
separate low-throughput calibration measurements [31].
Moreover, it is unclear how well SORTCERY, if applied
to a library of folded proteins rather than unstructured
peptides, can distinguish sequence-dependence effects on
affinity from sequence-dependent effects on protein ex-
pression and stability.
To enable massively parallel measurements of abso-
lute binding affinities for antibodies and other structured
proteins, we have developed an assay called “Tite-Seq.”
Tite-Seq, like SORTCERY, builds on the capabilities of
Sort-Seq, an experimental strategy that was first devel-
oped for studying transcriptional regulatory sequences in
bacteria [34]. Sort-Seq combines fluorescence-activated
cell sorting (FACS) with high-throughput sequencing to
provide massively parallel measurements of cellular flu-
orescence. In the Tite-Seq assay, Sort-Seq is applied to
antibodies displayed on the surface of yeast cells and in-
cubated with antigen at a wide range of concentrations.
From the resulting sequence data, thousands of antibody-
antigen binding titration curves and their corresponding
absolute dissociation constants (here denoted KD) can be
inferred. By assaying full binding curves, Tite-Seq is able
to measure affinities over many orders of magnitude [35].
Moreover, the resulting sequence-dependent affinity val-
ues are not confounded by potential sequence-dependent
variation in protein expression or stability, as is the case
with SORTCERY and other DMS assays.
We demonstrated Tite-Seq on a protein library derived
from a well-studied single-chain variable fragment (scFv)
antibody specific to the small molecule fluorescein [7, 36].
Mutations were restricted to CDR1H and CDR3H re-
gions, which are known to play an important role in the
antigen recognition of this scFv [36, 37]. The result-
ing affinity measurements were validated with binding
curves for a handful of clones measured using standard
low-throughput flow cytometry. Our Tite-Seq measure-
ments reveal both expected and unexpected differences
between the effects of mutations in CDR1H and CDR3H.
These data also shed light on structural aspects of antigen
recognition that are independent of effects on antibody
stability.
II. RESULTS
A. Overview of Tite-Seq
Our general strategy is illustrated in Fig. 1. First,
a library of variant antibodies is displayed on the sur-
face of yeast cells (Fig. 1A). The composition of this li-
brary is such that each cell displays a single antibody
variant, and each variant is expressed on the surface of
multiple cells. Cells are then incubated with the anti-
gen of interest, bound antigen is fluroescently labeled,
and fluorescence-activated cell sorting (FACS) is used to
sort cells one-by-one into multiple “bins” based on this
fluorescent readout (Fig. 1B). Deep sequencing is then
used to survey the antibody variants present in each bin.
Because each variant antibody is sorted multiple times,
it will be associated with a histogram of counts spread
across one or more bins (Fig. 1C). The spread in each
histogram is due to cell-to-cell variability in antibody ex-
pression, and to the inherent noisiness of flow cytometry
measurements. Finally, the histogram corresponding to
each antibody variant is used to compute an “average bin
number” (Fig. 1C, dots), which serves as a proxy mea-
surement for the average amount of bound antigen per
cell.
It has previously been shown that KD values can be
accurately measured using yeast-displayed antibodies by
taking binding titration curves, i.e., by measuring the
average amount of bound antigen as a function of anti-
gen concentration [8, 38]. The median fluorescence f of
labeled cells is expected to be related to antigen concen-
tration via
f = A
c
c+KD
+B (1)
where A is proportional to the number of functional an-
tibodies displayed on the cell surface, B accounts for
background fluorescence, and c is the concentration of
free antigen in solution. Fig. 1D illustrates the shape
of curves having this form. By using flow cytometry
to measure f on clonal populations of yeast at differ-
ent antigen concentrations c, one can infer curves having
the sigmoidal form shown in Eq. 1 and thereby learn KD.
Such measurements, however, can only be performed in
a low-throughput manner.
Tite-Seq allows thousands of binding titration curves
to be measured in parallel. The Sort-Seq procedure il-
lustrated in Fig. 1A-C is performed at multiple antigen
concentrations, and the resulting average bin number for
each variant antibody is plotted against concentration.
Sigmoidal curves are then fit to these proxy measure-
ments, enabling KD values to be inferred for each vari-
ant.
We emphasize that KD values cannot, in general, be
accurately inferred from Sort-Seq experiments performed
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FIG. 1. Schematic illustration of Tite-Seq. (A) A li-
brary of variant antibodies (various colors) are displayed on
the surface of yeast cells (tan). (B) The library is exposed
to antigen (green triangles) at a defined concentration, cell-
bound antigen is fluorescently labeled, and FACS is used to
sort cells into bins according to measured fluorescence. (C)
The antibody variants in each bin are sequenced and the dis-
tribution of each variant across bins is computed (histograms;
colors correspond to specific variants). The mean bin number
(dot) is then used to quantify the typical amount of bound
antigen per cell. (D) Binding titration curves (solid lines)
and corresponding KD values (vertical lines) can be inferred
for individual antibody sequences by using the mean fluores-
cence values (dots) obtained from flow cytometry experiments
performed on clonal populations of antibody-displaying yeast.
(E) Tite-Seq consists of performing the Sort-Seq experiment
in panels A-C at multiple antigen concentrations, then infer-
ring binding curves using mean bin number as a proxy for
mean cellular fluorescence. This enables KD measurements
for thousands of variant antibodies in parallel. We note that
the Tite-Seq results illustrated in panel E were simulated us-
ing three bins under idealized experimental conditions, as de-
scribed in Appendix A. The inference of binding curves from
real Tite-Seq data is more involved than this panel might sug-
gest, due to the multiple sources of experimental noise that
must be accounted for.
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FIG. 2. Yeast display construct and antibody li-
braries. (A) Co-crystal structure of the 4-4-20 (WT) anti-
body from [39] (PDB code 1FLR). The CDR1H and CDR3H
regions are colored blue and red, respectively. (B) The yeast
display scFv construct from [7] that was used in this study.
Antibody-bound antigen (fluorescein) was visualized using PE
dye. The amount of surface-expressed protein was separately
visualized using BV dye. Approximate location of the CDR1H
(blue) and CDR3H (red) regions within the scFv are illus-
trated. (C) The gene coding for this scFv construct, with
the six CDR regions indicated. The WT sequence of the two
10 aa variable regions are also shown. (D) The number of
1-, 2-, and 3-codon variants present in the 1H and 3H scFv
libraries. Fig. S1 shows the cloning vector used to construct
the CDR1H and CDR3H libraries, as well as the form of the
resulting expression plasmids.
at a single antigen concentration. Because the relation-
ship between binding and KD is sigmoidal, the amount
of bound antigen provides a quantitative readout of KD
only when the concentration of antigen used in the label-
ing procedure is comparable in magnitude to KD. How-
ever, single mutations within a protein binding domain
often change KD by multiple orders of magnitude. Sort-
Seq experiments used to measure sequence-affinity land-
scapes must therefore be carried out over a range of con-
centrations large enough to encompass this variation.
Furthermore, as illustrated in Figs. 1C and 1D, dif-
ferent antibody variants often lead to different levels of
functional antibody expression on the yeast cell surface.
If one performs Sort-Seq at a single antigen concentra-
tion, high affinity (low KD) variants with low expression
(blue variant) may bind less antigen than low affinity
(high KD) variants with high expression (orange vari-
ant). Only by measuring full titration curves can the
effect that sequence has on affinity be deconvolved from
sequence-dependent effects on functional protein expres-
sion.
4B. Proof-of-principle Tite-Seq experiments
To test the feasibility of Tite-Seq, we used a well-
characterized antibody-antigen system: the 4-4-20 sin-
gle chain variable fragment (scFv) antibody [7], which
binds the small molecule fluorescein with KD = 1.2 nM
[8]. This system was used in early work to establish the
capabilities of yeast display [7], and a high resolution
co-crystal structure of the 4-4-20 antibody bound to flu-
orescein, shown in Fig. 2A, has been determined [39]. An
ultra-high-affinity (KD = 270 fM) variant of this scFv,
called 4m5.3, has also been found [36]. In what follows,
we refer to the 4-4-20 scFv from [7] as WT, and the 4m5.3
variant from [36] as OPT.
The scFv was expressed on the surface of yeast as
part of the multi-domain construct illustrated in Fig.
2B and previously described in [7]. Following [36], we
used fluorescein-biotin as the antigen and labeled scFv-
bound antigen with streptavidin-RPE (PE). The amount
of surface-expressed protein was separately quantified by
labeling the C-terminal c-Myc tag using anti-c-Myc pri-
mary antibodies, followed by secondary antibodies con-
jugated to Brilliant Violet 421 (BV). See Appendix B for
details on this labeling procedure.
Two different scFv libraries were assayed simultane-
ously. In the “1H” library, a 10 aa region encompasing
the CDR1H region of the WT scFv (see Fig. 2C) was
mutagenized using a microarray-synthesized oligos (see
Appendix C for details on library generation). The re-
sulting 1H library consisted of all 600 single-codon vari-
ants of this 10 aa region, 1100 randomly chosen 2-codon
variants, and 150 random 3-codon variants (Fig. 2D). An
analogous “3H” library was generated for a 10 aa region
containing the CDR3H region of this scFv. In all of the
Tite-Seq experiments described below, these two libraries
were pooled together and supplemented with WT and
OPT scFvs, as well with a nonfunctional scFv referred
to as ∆.
Tite-Seq was carried out as follows. Yeast cells ex-
pressing scFv from the mixed library were incubated with
fluorescein-biotin at one of eleven concentrations: 0 M,
10−9.5 M, 10−9 M, 10−8.5 M, 10−8 M, 10−7.5 M, 10−7
M, 10−6.5 M, 10−6 M, 10−5.5 M, and 10−5 M. After sub-
sequent PE labeling of bound antigen, cells were sorted
into four bins using FACS (Fig. 3A). Separately, BV-
labeled cells were sorted according to measured scFv ex-
pression levels (Fig. 3B). The number of cells sorted into
each bin is shown in Fig. 3C. Each bin of cells was re-
grown and bulk DNA was extracted. The 1H and 3H
variable regions were then PCR amplified and sequenced
using paired-end Illumina sequencing, as described in Ap-
pendix D. The final data set consisted of an average of
2.6× 106 sequences per bin across all 48 bins (Fig. 3D).
Three independent replicates of this experiment were per-
formed on three different days.
For each variant scFv gene, a KD value was inferred
by fitting a binding curve to the resulting Tite-Seq data,
with separate curves independently fit to data from each
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FIG. 3. Details of our Tite-Seq experiments. (A) Gates
used to sort cells based on PE fluorescence, which provides a
readout of bound antigen. Cells were labeled at the eleven
different antigen concentrations. Shades of red indicate the
four fluorescence gates used to sort cells; these correspond to
bins 0,1,2, and 3 (from left to right). (B) Gates, indicated in
shades of purple, used to sort cells based on BV fluorescence,
which provides a readout of antibody expression. (C) The
number of cells sorted into each bin. (D) The number of
Illumina reads obtained from each bin of sorted cells after
quality control measures were applied. The data shown in
this figure corresponds to a single Tite-Seq experiment. Fig.
S2 and Fig. S3 show data for two independent replicates of
this experiment.
Tite-Seq experiment (Fig. 4A). As illustrated in Fig. 1E,
this fitting procedure uses the sigmoidal function in Eq.
1 to model mean bin number as a function of antigen
concentration. However, the need to account for multiple
sources of noise in the Tite-Seq experiment necessitates
a more complex procedure than Fig. 1E might suggest;
the details of this inference procedure are described in
Appendix E.
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FIG. 4. Accuracy and precision of Tite-Seq. (A) Bind-
ing curves and KD measurements inferred from Tite-Seq data.
(B) Mean fluorescence values (dots) and corresponding in-
ferred binding curves (lines) obtained by flow cytometry mea-
surements for five selected scFvs (WT, OPT, C5, C45, and
C107). In (A,B), values corresponding to 0 M fluorescein are
plotted on the left-most edge of the plot, dotted lines show the
upper (10−5 M) and lower (10−9.5 M) limits onKD sensitivity,
vertical lines show inferred KD values, and different shades
correspond to different replicate experiments. (C) Compar-
ison of the Tite-Seq-measured and flow-cytometry-measured
KD values for all clones tested. Colors indicate different scFv
protein sequences as follows: WT (purple), OPT (green), ∆
(black), 1H clones (blue), and 3H clones (red). Each KD value
plotted along either axis indicates the mean log10KD value
obtained across all replicates, with error bars indicating stan-
dard error. Clones with KD outside of the affinity range are
drawn on the boundaries of this range, which are indicated
with dotted lines. The amino acid sequences and measured
KD values for all clones tested are provided in Table I. Fig.
S4 provides plots, analogous to those in panels A and B, for
all of the assayed clones. Fig. S5 compares the KD and E
values obtained across all three Tite-Seq replicates. Fig. S6
provides additional information about the composition of the
libraries assayed in each replicate experiment. Fig. S7 illus-
trates the poor correlation between the enrichment of scFvs
in the high-PE bins with the Tite-seq measured KD values.
Fig. S8 shows differences in the fraction of displayed receptors
that are functional in OPT and WT clones. Fig. S9 illustrates
the simulations we used to test our analysis pipeline, and Fig.
S10 illustrates the ability of our pipeline to correctly infer KD
values from these simulated data.
The Sort-Seq data obtained by sorting the BV-labeled
libraries were used to separately determine the expression
level of each scFv. In what follows we use E to denote
the mean bin computed for each scFv gene in the library.
These E values are scaled so that the mean of such mea-
surements for all synonymous WT scFv gene variants is
1.0.
C. Low-throughput validation experiments
To judge the accuracy of Tite-Seq, we separately mea-
sured binding curves for individual scFv clones as de-
scribed for Fig. 1D. In addition to the WT, OPT, and
∆ scFvs, we assayed eight clones from the 1H library
(named C3, C5, C7, C18, C22, C132, C133 and C144)
and eight clones from the 3H library (C39, C45, C93,
C94, C102, C103, C107, C112). Each clone underwent
the same labeling procedure as in the Tite-Seq experi-
ment, after which median fluorescence values were mea-
sured using standard flow cytometry. KD values were
then inferred by fitting binding curves of the form in Eq.
1 using the procedure described in Appendix F. These
curves, which can be directly compared to the Tite-Seq
measurement (Fig.4A), are plotted in Fig. 4B; at least
three replicate binding curves were measured for each
clone. See Fig. S4 for the titration curves of all the tested
clones.
D. Tite-Seq can measure dissociation constants
Fig. 4C reveals a strong correspondence between the
KD values measured by Tite-Seq and those measured
using low-throughput flow cytometry. The robustness
of Tite-Seq is further illustrated by the consistency of
KD values measured for the WT scFv. Using Tite-
Seq, and averaging the results from the 33 synonymous
variants and over all three replicates, we determined
KD = 10
−8.87±0.02 M for the WT scFv. These mea-
surements are consistent with the measurement of KD =
10−8.61±0.07 M obtained by averaging low-throughput
flow cytometry measurements across 10 replicates, and
coincides with the previously measured value of 1.2 nM
= 10−8.9 M reported in [8]. The three independent
replicate Tite-Seq experiments give reproducible results
(Fig. S5 and S6) with Pearson coefficients ranging from
r = 0.82 to r = 0.89 for all the measured KD values. The
error bars for KD values in Fig. 4C calculated from the
variability of the fits to different replicates support the
reproducibility of the experiment.
The necessity of performing KD measurements over a
wide range of antigen concentrations is illustrated in Fig.
S7. At each antigen concentration used in our Tite-Seq
experiments, the enrichment of scFvs in the high-PE bins
correlated poorly with the KD values inferred from full
titration curves. Moreover, at each antigen concentra-
tion used, a detectable correlation between KD and en-
6richment was found only for scFvs with KD values close
to that concentration.
Fig. S8 suggests a possible reason for the weak correla-
tion between KD values and enrichment in high-PE bins.
We found that, at saturating concentrations of fluorescein
(2µM), cells expressing the OPT scFv bound twice as
much fluorescein as cells expressing the WT scFv. This
difference was not due to variation in the total amount of
displayed scFv, which one might control for by labeling
the c-Myc epitope as in [33]. Rather, this difference in
binding reflects a difference in the fraction of displayed
scFvs that are competent to bind antigen. Yeast display
experiments performed at a single antigen concentration
cannot distinguish such differences in the fraction of dis-
played scFv molecules that function properly from differ-
ences in scFv affinity.
To further test the capability of Tite-Seq to infer disso-
ciation constants from sequencing data over a wide range
of values, as well as to validate our analysis procedures,
we simulated Tite-Seq data in silico and analyzed the re-
sults using the same analysis pipeline that we used for our
experiments. Details about the simulations are given in
Appendix G. The simulated data is illustrated in Fig. S9.
KD values inferred from these simulated data agreed to
high accuracy with the KD used in the simulation (Fig.
S10), thus validating our analysis pipeline.
E. Properties of the affinity and expression
landscapes
Fig. 5 shows the effect that every single-amino-acid
substitution mutation within the 1H and 3H variable re-
gions has on affinity and on expression; histograms of
these effects are provided in Fig. S11. In both regions,
the large majority of mutations weaken antigen binding
(1H: 88%; 3H: 93%), with many mutations increasing KD
above our detection threshold of 10−5 M (1H: 36%; 3H:
52%). Far fewer mutations reduced KD (1H: 12%; 3H:
7%), and very few dropped KD below our detection limit
of 10−9.5 M (1H: 0%; 3H: 3%). Histograms of the effect
of 2 or 3 amino acid changes relative to WT, shown in
Fig. S12A, show that multiple random mutations tend
to further deteriorate affinity. We also observed that
mutations within the 3H variable region have a larger
effect on affinity than do mutations in the 1H variable
region. Specifically, single amino acid mutations in 3H
were seen to increased KD more than mutations in 1H
(1H median KD = 10
−6.84; 3H median KD & 10−5.0;
P = 4.7× 10−4, one-sided Mann-Whitney U test). This
result suggests that binding affinity is more sensitive to
variation in CDR3H than to variation in CDR1H, a find-
ing that is consistent with the conventional understand-
ing of these antibody CDR regions [40, 41].
Our observations are thus fully consistent with the hy-
pothesis that the amino acid sequences of the CDR1H
and CDR3H regions of the WT scFv have been selected
for high affinity binding to fluorescein. We know this to
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FIG. 5. Effects of substitution mutations on affinity
and expression. Heatmaps show the measured effects on
affinity (A,B) and expression (C,D) of all single amino acid
substitutions within the variables regions of the 1H (A,C) and
3H (B,D) libraries. Purple dots indicate residues of the WT
scFv. Green dots indicate non-WT residues in the OPT scFv.
Fig. S11 provides histograms of the non-WT values displayed
in panels A-D. Fig. S12 compares the effects on KD of both
single-point and multi-point mutations.
be true, of course; still, this result provides an important
validation of our Tite-Seq measurements.
To further validate our Tite-Seq affinity measurements,
we examined positions in the high affinity OPT scFv
(from [36]) that differ from WT and that lie within the 1H
and 3H variable regions. As illustrated in Figs. 5A and
5B, five of the six OPT-specific mutations reduce KD or
are nearly neutral. Previous structural analysis [37] has
suggested that D106E, the only OPT mutation that we
find significantly increases KD, may indeed disrupt anti-
gen binding on its own while still increasing affinity in
the presence of the S101A mutation.
Next, we used our measurements to build a “matrix
model” [42] (also known as a “position-specific affinity
matrix,” or PSAM [43]) describing the sequence-affinity
landscape of these two regions. Our model assumed that
the log10KD value for an arbitrary amino acid sequence
could be computed from the log10KD value of the WT
scFv, plus the measured change in log10KD produced by
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FIG. 6. Structural context of mutational effects. (A)
Crystal structure [39] of the CDR1H and CDR3H variable re-
gions of the WT scFv in complex with fluorescein (green).
Each residue (CDR1H: positions 28-37; CDR3H: positions
100-109) is colored according to the SK and SE values com-
puted for that position. These variables, SK and SE , respec-
tively quantify the sensitivity of KD and E to amino acid
substitutions at each position, with larger values greater sen-
sitivity; see Eqs. 2 and 3 for definitions of these quantities.
(B,C) For each position in the CDR1H and CDR3H variable
regions, SK is plotted against either (B) the number of con-
tacts the WT residue makes within the protein structure, or
(C) the distance of the WT residue to the fluorescein molecule.
(D,E) Similarly, SE is plotted against either (D) the number
of contacts or (E) the distance to the antigen.
each amino acid substitution away from WT. We evalu-
ated our matrix models on the 1H and 3H variable re-
gions of OPT, finding an affinity of 10−9.16 M. Our sim-
ple model for the sequence affinity landscape of this scFv
therefore correctly predicts that OPT has higher affin-
ity than WT. The quantitative affinity predicted by our
model does not match the known affinity of the OPT scFv
(KD = 10
−12.6 M), but this is unsurprising for three rea-
sons. First the OPT scFv differs from WT in 14 residues,
only 6 of which are inside the 1H and 3H variable re-
gions assayed here. Second, one of the OPT mutations
(W108L) reduces KD below our detection threshold of
10−9.5 M; in building our matrix model, we set this value
equal to 10−9.5, knowing it would likely underestimate
the affinity-increasing effect of the mutation. Third, our
additive model ignores potential epistatic interactions.
Still, we thought it worth asking how likely it it would
be for 6 random mutations within the 1H and 3H vari-
able regions to reduce affinity as much as our model pre-
dicts for OPT. We therefore simulated a large number
(107) of variants having a total of 6 substitution muta-
tions randomly scattered across the 1H and 3H variable
regions. The fraction of these random sequences that had
an affinity at or below our predicted affinity for OPT was
4.7× 10−5. This finding is fully consistent with the fact
that the mutations in OPT relative to WT were selected
for increased affinity, an additional confirmation of the
validity of our Tite-Seq measurements.
The sequence-expression landscape measured in our
separate Sort-Seq experiment yielded qualitatively dif-
ferent results (Figs. 5C and 5D). We observed no signif-
icant difference in the median effect that mutations in
the variable regions of 1H (median E = 0.826) versus
3H (median E = 0.822) have on expression (P = 0.96,
two-sided Mann-Whitney U test); see also Fig. S11. The
variance in these effects, however, was larger in 3H than
in 1H (P = 9.9 × 10−16, Levene’s test). These results
suggest two things. First, the 3H variable region appears
to have a larger effect on scFv expression than the 1H
variable region has. At the same time, since we observe
fewer beneficial mutations in 1H (Fig. 5 C) than in 3H
(Fig. 5 D), the WT sequence appears to be more highly
optimized for expression in CDR1H than in CDR3H. The
effect of double or triple mutations further reduced ex-
pression in both CDRs (Fig. S12B), similar to what was
observed for affinity.
F. Structural correlates of the sequence-affinity
landscape
We asked if the sensitivity of the antibody to muta-
tions could be understood from a structural perspective.
To quantify sensitivity of affinity and expression at each
position i, we computed two quantities:
SiK =
√〈(
log10K
ia
D − log10KWTD
)2〉
a|i
, (2)
SiE =
√〈
(Eia − EWT)2
〉
a|i
. (3)
Here, KWTD and E
WT respectively denote the dissociation
constant and expression level measured for the WT scFv,
8KiaD and E
ia denote analogous quantities for the scFv
with a single substitution mutation of amino acid a at
position i, and 〈·〉a|i denotes an average computed over
the 19 non-WT amino acids at that position.
Fig. 6A shows the known structure [39] of the 1H and
3H variable regions of the WT scFv in complex with flu-
orescein. Each residue is colored according to the SK
and SE values computed for its position. To get a bet-
ter understanding of what aspects of the structure might
govern affinity, we plotted SK values against two other
quantities: the number of amino acid contacts made by
the WT residue within the antibody structure (Fig. 6B),
and the distance between the WT residue and the anti-
gen (Fig. 6C). We found a strong correlation between SK
and the number of contacts, but no significant correlation
between SK and distance to antigen. By contrast, SE did
not correlate significantly with either of these structural
quantities (Figs. 6D and 6E).
III. DISCUSSION
We have described a massively parallel assay, called
Tite-Seq, for measuring the sequence-affinity landscape
of antibodies. The range of affinities measured in our
Tite-Seq experiments (10−9.5 M to 10−5.0 M) includes a
large fraction of the physiological range relevant to affin-
ity maturation (10−10 M to ∼ 10−6 M to) [44–46]. Ex-
panding the measured range of affinities below 10−9.5 M
might require larger volume labeling reactions, but would
be straight-forward. Tite-Seq therefore provides a poten-
tially powerful method for mapping the sequence-affinity
trajectories of antibodies during the affinity maturation
process, as well as for studying other aspects of the adap-
tive immune response.
Tite-Seq fundamentally differs from prior DMS exper-
iments in that full binding titration curves, not enrich-
ment statistics, are used to determine binding affinities.
The measurement of binding curves provides three ma-
jor advantages. First, binding curves provide absolute
KD values in molar units, not just rank-order affinities
like those provided by SORTCERY [31]. Second, be-
cause ligand binding is a sigmoidal function of affinity,
DMS experiments performed at a single ligand concen-
tration are insensitive to receptor KDs that differ sub-
stantially from this ligand concentration. Yet mutations
within a protein’s binding domain often change KD by
multiple orders of magnitude. Binding curves, by con-
trast, integrate measurements over a wide range of con-
centrations and are therefore sensitive to a wide range of
KDs. Third, protein sequence determines not just ligand-
binding affinity, but also the amount of surface-displayed
protein, as well as the fraction of this protein that is func-
tional. Our data demonstrate that these confounding ef-
fects can strongly distort yeast display affinity measure-
ments made at a single antigen concentration, and that
the binding curves measured by Tite-Seq successfully de-
convolve these effects from affinity measurements.
More generally, changing a protein’s amino acid se-
quence can be expected to change multiple biochemical
properties of that protein. Our work emphasizes the im-
portance of designing massively parallel assays that can
disentangle these multiple effects so that measurements
of a specific activity of interest can be obtained. Tite-
Seq provides a general solution to this problem for mas-
sively parallel studies of protein-ligand binding. Indeed,
the Tite-Seq procedure described here can be readily ap-
plied to any protein binding assay that is compatible with
yeast display and FACS. Many such assays have been de-
veloped [47]. We expect that Tite-Seq can also be readily
adapted for use with other expression platforms, such as
mammalian cell display [9].
Our Tite-Seq measurements reveal interesting distinc-
tions between the effects of mutations in the CDR1H
and CDR3H regions of the anti-fluorescein scFv anti-
body studied here. As expected, we found that varia-
tion in and around CDR3H had a larger effect on affinity
than variation in and around CDR1H. We also found
that CDR1H is more optimized for protein expression
than is CDR3H, an unexpected finding that appears to
be novel. Yeast display expression levels are known to
correlate with thermostability [48]. Our data is limited
in scope, and we remain cautious about generalizing our
observations to arbitrary antibody-antigen interactions.
Still, this finding suggests the possibility that secondary
CDR regions (such as CDR1H) might be evolutionar-
ily optimized to help ensure antibody stability, thereby
freeing up CDR3H to encode antigen specificity. If this
hypothesis holds, it could provide a biochemical rationale
for why CDR3H is more likely than CDR1H to be mu-
tated in functioning receptors [41] and why variation in
CDR3H is often sufficient to establish antigen specificity
[40].
Tite-Seq can also potentially shed light on the struc-
tural basis for antibody-antigen recognition. By compar-
ing the effects of mutations with the known antibody-
fluorescein co-crystal structure [39], we identified a strong
correlation between the effect that a position has on affin-
ity and the number of molecular contacts that the residue
at that position makes within the antibody. By contrast,
no such correlation of expression with this number of
contacts is observed. Again, we are cautious about gen-
eralizing from observations made on a single antibody. If
our observation were to hold for other antibodies, how-
ever, it would suggest that paratopes might represent
protein “sectors” [49], with antigen specificity (but not
antibody stability) governed by tightly interacting net-
works of residues.
IV. METHODS
Tite-Seq was performed as follows. Variant 3H and
1H regions were generated using microarray-synthesized
oligos (LC Biosciences, Houston TX. USA). These were
inserted into the 4-4-20 scFv of [7] using cassette-
9replacement restriction cloning as in [34]; see Appendix
C. Yeast display experiments were performed as previ-
ously described [36] with modifications; see Appendix B.
Sorted cells were regrown and bulk DNA was extracted
using standard techniques, and amplicons containing the
1H and 3H variable regions were amplified using PCR
and sequenced using the Illumina NextSeq platform; see
Appendix D. Three replicate experiments were performed
on different days. Raw sequencing data has been posted
on the Sequence Read Archive under BioProject ID PR-
JNA344711. Low-throughput flow cytometry measure-
ments were performed on clones randomly picked from
the Tite-Seq library. Sequence data and flow cytometry
data were analyzed using custom Python scripts, as de-
scribed in Appendices E and F. Processed data and anal-
ysis scripts are available at github.com/jbkinney/
16_titeseq.
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Appendix A: Schematic simulations
For panels D and E of Fig. 1, data was simulated (us-
ing Eq. 1) for two hypothetical scFvs: one similar to
WT, with KD = 1.2 × 10−9 M, A = 300, and B = 10,
and one similar to a typical mutant, with KD = 10
−6
M, A = 1000, B = 10. Simulated sorts were performed
at the eleven antigen concentrations used in our exper-
iments (c = 0 M, 10−9.5 M, 10−9.0 M, . . . , 10−5.0 M).
For each clone at each antigen concentration, fluores-
cence signals were simulated for 1000 cells by multiplying
the f quantity in Eq. 1 by a factor of exp(η) where η is
a normally distributed random number. Fig. 1D shows
the mean values of these simulated fluorescence signals.
Curves of the form in Eq. 1 were fit to these data by min-
imizing the square deviation between predicted log10 f
values and the log10 mean of the simulated fluoresence
values. The Tite-Seq measurements illustrated in Fig.
1E were simulated by sorting 1000 cells, using fluores-
cence values generated in the same manner as above, into
three bins defined by the following fluorescence bound-
aries: (0, 30) for bin 0, (30, 300) for bin 1, and (300,∞)
for bin 2. The mean bin number for each clone at each
antigen concentration was then computed. Curves hav-
ing the form in Eq. 1 were then fit to these data by min-
imizing the square deviation of predicted log10 f values
from these mean bin values.
Appendix B: Yeast display
To help ensure consistency across samples, the yeast
display cultures used in our low-throughput flow cytom-
etry measurements and in our Tite-Seq experiments were
inoculated with carefully prepared frozen liquid culture
inocula. Specifically, inoculation cultures were grown at
30◦C in SC-trp + 2% glucose to an OD600 value between
0.9 and 1.1, then stored at −80◦ in aliquots containing
10% glycerol and either 0.4 ml·OD of cells (for clones) or
1 ml·OD of cells (for libraries).
The expression of yeast-displayed scFvs was induced as
follows. Liquid cultures of SC-trp + 2% glucose were in-
oculated using single frozen inocula, yielding an approx-
imate starting OD of 0.05. These cultures were grown at
30◦C for 8 hours; the final OD of these cultures was ap-
proximately 0.7. Cells were then spun down at 1932 g for
8 minutes at 4◦C, resuspended in SC-trp + 2% galactose
+ 0.1% glucose at 0.2 OD, and incubated for 16 hr at
20◦C. We note that adding 0.1% glucose to these galac-
tose induction cultures was essential for reliably achieving
scFv expression in a large fraction of yeast cells.
Induced yeast were fluorescently labeled as follows.
Galactose induction cultures were spun down and washed
with ice cold TBS-BSA (0.2 mg/ml BSA, 50 mM Tris,
25 mM NaCl, pH 8). This yielded approximately 5.3
ml·OD of cells for tite-seq FACS. For antigen binding re-
actions, cells were then resuspended in a primary label-
ing reaction containing 40 ml TBS-BSA and biotinylated
fluorescein (ThermoFisher B1370) at a concentration be-
tween 0 M and 10−5 M, then incubated with shaking for 1
hour at room temperature. Reaction volumes were large
enough to ensure that & 10 antigen molecules per scFv
were present, assuming ∼ 105 scFvs per cell [7]. Cells
were then washed twice with 40 ml ice cold TBS-BSA,
suspended in a secondary labeling reaction containing 1
ml ice-cold TBS-BSA and 7 µg/ml streptavidin R-PE
(ThermoFisher S866), and incubated for 30 min at 4◦C
while shaking. Cells were then spun down and resus-
pended in ice cold TBS-BSA and saved for FACS later
that day. Expression labeling reactions proceeded in the
same manner, except that the primary labeling reaction
contained 1.4 µg/ml rabbit anti-c-Myc antibody (Sigma-
Aldrich C3956) in place of the antigen, and the secondary
labeling reaction contained 0.8 µg/ml BV421-conjugated
donkey anti-rabbit antibody (BioLegend 406410) in place
of streptavidin R-PE. The labeling reactions used to filter
out improperly cloned scFvs (as described in Appendix
C) proceeded in the same manner as the expression label-
ing reaction, except that 0.8 µg/ml mouse anti-HA an-
tibody (Roche 11583816001) was added to the primary
labeling reaction, while 0.4 µg/ml APC-conjugated anti-
mouse antibody (BD Biosciences 550826) was added to
the secondary labeling reaction. For clonal flow cytome-
try measurements, excluding secondary labeling we kept
reagent and cell concentrations the same as described
above, but reduced reaction volumes 27-fold. Secondary
labeling reactions with streptavidin R-PE were done at
10
4 µg/ml 112.5 µl to facilitate mixing. Secondary label-
ing reactions with 0.8 µg/ml BV421-conjugated donkey
anti-rabbit antibody were performed in 60 µl.
Appendix C: Cloning strategy
Amplicons containing variable CDR1H or CDR3H re-
gions were generated as follows. An oligonucleotide li-
brary containing mutagenized 1H and 3H variable re-
gions (see Table II) was generated by LC Sciences
using microarray-based synthesis. The specific oli-
gos used are provided at github.com/jbkinney/16_
titeseq. 1H and 3H library oligos were separately am-
plified via PCR using primers oRAL10 and oRAR10 (for
1H) or oRAL11 and oRAR11 (for 3H). Oligos containing
the WT sequence were amplified from plasmid pCT302
[7] using primers 1H2F and 1H1R (for the 1H region) or
3H1F and 3H2R (for the 3H region). Overlap-extension
PCR using primers oRA10 and oRA11, one oligo library
(1H or 3H) and the complementary WT oligo (3H or 1H,
respectively), and plasmid pCT302, were then used to
create the iRA11 amplicon library (Fig. S1A). Note that
each amplicon in this library has mutations only in the
1H variable region or in the 3H variable region, but not
in both of these regions.
The pRA10 cloning vector (Fig. S1B) was assem-
bled using Gibson cloning [50] with template plasmids
pCT302 [7] and pJK14 [34]. pCT302 is the yeast dis-
play expression plasmid containing the WT scFv. pJK14
contains a ccdB cloning cassette flanked by outward-
facing BsmBI restriction sites. pRA10 closely resembles
pCT302, except that it contains the ccdB cassette from
pJK14 in place of the region of the scFv gene that we
aimed to mutagenize. Multiple spurious BsmBI restric-
tion sites present pCT302 were also removed in pRA10.
pRA10 was propagated in Escherichia coli strain DB3.1,
which is resistant to the CcdB toxin.
The pRA11 plasmid library (Fig. S1C) was gener-
ated by digesting pRA10 with BsmBI, digesting the
iRA11 amplicon library with BsaI, and subsequent lig-
ation with T4 DNA ligase. Ligation reactions were de-
salted and transformed into DH10B E. coli via electro-
poration, yielding & 108 transformants. The 1H and 3H
libraries were cloned separately.
The pRA11 libraries were introduced into the EBY100
strain of Saccharomyces cerevisiae using high-efficiency
LiAc transformation [51]. This yielded & 105 transfor-
mants. To filter out yeast containing improperly cloned
scFvs, we induced scFv expression, immuno-affinity la-
beled the HA and c-Myc epitopes on the scFv, and used
FACS to recover 8×105−2×106 cells that registered pos-
itive for both epitopes. The scFv induction and labeling
procedures used to do this are described in Appendix B.
144 yeast clones were picked at random from this library
and submitted for low-throughput Sanger sequencing of
the 1H and 3H variable regions of the scFv. Based on
preliminary Tite-Seq experiments, 19 of these clones were
then chosen for low-throughput KD measurements.
Appendix D: Tite-Seq procedure
The inocula used for our Tite-Seq experiments com-
prised yeast harboring the 1H and 3H pRA11 plasmid li-
braries, mixed in equal proportions, and spiked at 0.625%
with OPT-containing yeast (as a positive control) and at
0.625% with ∆-containing yeast (negative control). Cells
were then grown, induced, and labeled with antigen at
eleven different concentrations (0 M, 10−9.5 M, 10−9.0 M,
. . . , 10−5.0 M) as described in Appendix B.
Each batch of labeled cells was then sorted, using
FACS, over a period of approximately 20 min. During
FACS, cells were first filtered based on forward scatter
and side scatter to help ensure exactly one live cell per
droplet. Cells passing this criterion were sorted into 4
bins based on R-PE fluorescence. The fluorescence gates
used in these sorts were kept the same across all antigen
concentrations (see Figs. 3, S2, and S3). Cells were sorted
into a rounded 5 ml polypropylene tube containing 1 ml
2X YPAD media. In our separate Sort-Seq experiments
assaying scFv expression levels, cells were prepared and
sorted in the same way, save for the changes to the label-
ing reaction described in Appendix B and the use of gates
on BV421 fluorescence instead of R-PE fluorescence.
Each of the 48 bins of sorted cells, as well as a sample
of unsorted cells, were then deposited in 5 ml of SC-trp
+ 2% glucose and regrown overnight at 30◦C. Approxi-
mately 25 ml·OD of cells were spun down, resuspended
in a lysis reaction containing 200 µl 0.5 mm glass beads,
200 µl of Phenol/chloroform/isoamyl alcohol and 200 µl
of yeast lysis buffer (10 mM NaCl, 1 mM Tris, 0.1 mM
EDTA, 0.2% Triton X-100, 0.1% SDS), and vortexed for
30 min. 200 µl of water was added, cells were spun down,
and the aqueous layer was extracted. Four subsequent
extractions were performed, the first two using 200 µl of
Phenol/chloraform/isoamyl alcohol, the second two us-
ing 200 µl for chloroform/isoamyl alcohol. Bulk nucleic
acid was then ethanol precipitated and resuspended in
100 µl of IDTE (Integrated DNA Technologies).
Two rounds of PCR were then performed on each of
the 49 samples of bulk nucleic acid. In the first round of
PCR, primers L1AF XX and L2AF XX were used to am-
plify the 1H-to-3H region and to add a bin-specific bar-
code (numbered XX = 01, 02, . . ., 64) on either end of the
1H-to-3H region; see Fig. S1. To keep PCR crossover to a
minimum, only 15 PCR cycles were used. These 49 PCR
reactions were then pooled, purified using a QIAquick
PCR purification kit (Qiagen), and used as template for
second round of PCR with primers PE1v3ext and PE2v3.
Again, to keep crossover to a minimum, only 25 PCR cy-
cles were used. This PCR reaction was again purified,
mixed with PhiX DNA (at ∼ 25% molarity) and submit-
ted for sequencing using the Illumina NextSeq platform.
Analysis of the resulting sequence data revealed some
of the 49 FACS bins to be highly under-sampled. PCR
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amplicons were therefore prepared for the under-sampled
bins from all three replicate experiments (using different
barcodes than before) and submitted for a fourth round
of sequencing.
Appendix E: Inference of KD from Tite-Seq data
We modeled the binding titration curve of each se-
quence – i.e., the curve describing how mean cellular
fluorescence depends on antigen concentration – using
a non-cooperative Hill function. Making the dependence
on scFv sequence s and antigen concentration c explicit,
Eq. 1 of the main text becomes
fsc = As
c
c+KD,s
+B, (E1)
where fsc denotes the mean fluorescence of cells carrying
sequence s and labeled with antigen at concentration c.
B represents the autofluorescence of cells, and was set
equal to the mean fluorescence of cells labeled at 0 M
antigen. As is the increase in fluorescence due to sat-
uration of all surface-displayed scFvs, and KD,s is the
dissociation constant for sequence s. We inferred As and
KD,s, for all sequences s, as follows.
Tite-Seq does not provide direct measurements of the
fluorescence fsc. Instead, we approximated this quantity
using a weighted averaged over sorting bins. Specifically,
we assumed that
log fsc ≈
∑
b
pb|sc Fbc. (E2)
Here, Fbc is the mean log fluorescence of the cells that
were sorted at concentration c into bin b, and pb|sc is
the probability that a cell having sequence s and labeled
at concentration c, if sorted, would be found in bin b.
Values for Fbc were computed directly from the FACS
data log. The probabilities pb|sc, by contrast, were in-
ferred from Tite-Seq read counts. These probabilities
are closely related to Rbsc, the number of sequence reads
for each sequence s from bin b at antigen concentration
c. This relationship is complicated by additional factors
that arise from variability in sequencing depth from bin
to bin. Moreover, because there were often a small num-
ber of reads for any particular sequence in a given bin,
it was necessary in our inference procedure to treat the
relationship between pb|sc and Rbsc probabilistically.
We therefore inferred values for the probabilities pb|sc
through the following maximum likelihood procedure.
First, we assumed that the number of reads Rbsc is re-
lated to an “expected” number of reads rbsc via a Poisson
distribution. The log likelihood of observing a specific set
of read counts Rbsc over all bins b and concentrations c
for a given sequence s is therefore given by
Ls = log
∏
b,c
1
Rbsc!
rbsc
Rbsce−rbsc
 . (E3)
The expected number of reads rbsc is, in turn, related to
the probability pb|sc via
rbsc =
Rbc
Cbc
Cc Ps pb|sc. (E4)
Here, Rbc =
∑
sRbsc is the total number of reads from
bin b at antigen concentration c, Cbc is the number of
cells sorted into bin b at antigen concentration c (ob-
tained from the FACS data log), Cc =
∑
b Cbc is the
total number of cells sorted at concentration c, and Ps is
the fraction of cells in the library with sequence s. The
factor RbcCc/Cbc in Eq. E4 accounts for differences in the
depth with which each bin was sequenced. Note: Eq. E3
assumes that each final read arose from a different sorted
cell. This assumption is clearly violated if Rbc > Cbc. In
cases where this inequality was found to hold, we rescaled
all Rbsc → hRbsc where h = Cbc/Rbc before undertaking
further analysis.
For each sequence s, we inferred KD,s, As, Ps, and
all probabilities pb|sc by maximizing the likelihood Ls
subject to the constraint that∑
b
pb|sc Fbc = ln
(
As
c
c+KD,s
+B
)
(E5)
at every concentration c. Note that, in this procedure,
the sorting probabilities pb|sc are not modeled explicitly
as a function of the putative mean fluorescence. Instead,
they are inferred from the data along with the parameters
of the non-cooperative Hill function. Doing this dispenses
with the need for a detailed characterization of the noise
in the Tite-Seq sorting procedure. The validity of this
procedure is evinced by the analysis of simulated data,
shown in Fig. S10.
The maximum likelihood optimization problem de-
scribed above was solved as follows. For each con-
centration c, we created a grid of 100 equally spaced
points for ln fsc ∈ [F0a, F3a]. For each possible value
of fsc, we then used Nelder-Mead optimization of pb|sc
to minimize Ls under the constraint in Eq. E5. Akima
interpolation was then used to create a function of
the optimized probability pˆb|sc as a function of fsc.
We then scanned a 321× 201 grid of values for the
pair (KD,s, As) and selected the pair that minimized
Ls(KD,s, As,
{
pˆb|sc(KD,s, As), Ps
}
b,c
). We repeated this
scan by varying Ps over 95 different values. The final in-
ferred values for KD,s, As, and Ps were those so found to
maximize Ls. Python code for this inference procedure
is provided at github.com/jbkinney/16_titeseq.
Appendix F: Inference of KD from flow cytometry
experiments on individual clones
Low-throughput flow cytometry measurements per-
formed on clonal cell populations were used to measure
fsc,flow, the mean fluoresence of cells carrying sequence s
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and labeled at antigen concentration c. As for the Tite-
Seq inference procedure described in Appendix E, it was
assumed that fsc,flow could be modeled using the non-
cooperative Hill function Asc/(c+KD,s) +B, where As
is the increase in mean fluorescence due to fully labeled
scFvs of sequence s, KD,s is the corresponding dissocia-
tion constant, and B is background fluorescence. B was
computed from the average fluorescein of clone s at 0
M fluorescein. As and KD,s were then inferred by mini-
mizing the square deviation between measured ln fsc,flow
values and log Hill function predictions, i.e.,
∑
c
[
ln fsc,flow − ln
(
As
c
c+KD,s
+B
)]2
. (F1)
This optimization procedure was performed using a grid
search algorithm in which KD,s was restricted to the in-
terval [10−10M, 10−3M ] and As was restricted to the in-
terval [Aˆ, 100Aˆ] where Aˆ denotes the average range of flu-
orescence values over the 4-to-8 clones assayed per flow
cytometry session.
Appendix G: Realistic Tite-Seq simulations
In order to test our analysis pipeline, we simulated real-
istic Tite-Seq data and analyzed it with the same scripts
that we used on real data. For each sequence s, a KD,s
value was randomly drawn from the interval [10−10 M,
10−4 M] using a uniform distribution in log space, and
an As value was drawn uniformly from a uniform distri-
bution spanning the bulk of experimentally observed A
values. At each of the eleven antigen concentrations c,
we then modeled the distribution of cellular fluorescence
using a Gaussian Mixture Model (GMM) in log space.
Specifically, letting x denote log10 cellular fluorescence
values, we assumed that the probability density describ-
ing x to be
Psc(x) =
α
σ0
√
2pi
e
− (x−µ0)2
2σ20 +
1− α
σ1
√
2pi
e
− (x−µsc)2
2σ21 , (G1)
where α = 0.2 is the fraction of non-expressing cells, µ0 =
4.77 and σ0 = 1 are the mean and standard deviation
of x values for dark cells, and σ1 = 0.5 is the standard
deviation of x values for scFv-expressing cells. The mean
x value of scFv-expressing cells, here denoted µcs, was
chosen so that the population average of x is given by
the Hill function in Eq. E1, i.e., so that
〈x〉Psc = As
c
c+KD,s
+B. (G2)
The left hand side of Eq. G2 can be computed analyti-
cally using Eq. G1. Doing this and solving for µsc gives
µsc = ln
(
Asc
c+KD,s
+B − αeµ0+σ20/2
)
− ln(1−α)− σ
2
1
2
;
(G3)
this is the specific formula we used to compute µsc as a
function of c, As, and KD,s. Next we computed exact
pb|sc values using
pb|sc =
∫ b+
b−
dxPsc(x), (G4)
where b+ and b− are the upper and lower fluorescence
bounds used for bin b in our Tite-Seq experiment (repli-
cate number 1). These values were then used to draw
read counts Rbsc for each sequence s values via
Rbsc ∼ Bionomial(n = ksRbc, p = pb|sc), (G5)
where ks is a random variable, uniformly distributed on
a log scale between 0.01 and 100, used to represent noise
due to PCR jackpotting. Data thus simulated for WT
values of KD and A are shown in Fig. S9.
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Name 1H variable region 3H variable region no. replicates (flow) KD [M] (flow) KD [M] (Tite-Seq)
OPT TFghYWMNWV GasYGMeYlG 3 . 10−9.5 . 10−9.5
C107 TFSDYWMNWV GaYYGMDYWG 3 10−9.28±0.04 10−9.18±0.11
C112 TFSDYWMNWV GSYYGMDYcG 3 10−8.95±0.07 10−9.19±0.14
WT TFSDYWMNWV GSYYGMDYWG 10 10−8.61±0.07 10−8.92±0.10
C144 vFSDYWMNWV GSYYGMDYWG 3 10−8.57±0.03 10−8.86±0.04
C133 aFSDYWMNWV GSYYGMDYWG 3 10−8.55±0.06 10−8.62±0.09
C132 TFmDYWlNWV GSYYGMDYWG 3 10−8.48±0.08 10−8.38±0.29
C94 TFSDYWMNWV GSYYGMDsWG 3 10−8.46±0.06 10−8.50±0.04
C5 TFSDYWiNWV GSYYGMDYWG 3 10−8.34±0.10 10−8.55±0.09
C93 TFSDYWMNWV GSYrGMDYWG 3 10−7.35±0.08 10−7.60±0.70
C39 TFSDYWMNWV GSYYGMDYWa 3 10−7.08±0.20 10−7.28±0.17
C102 TFSDYWMNWV sSkYGMDYWG 3 10−5.76±0.16 10−7.25±0.60
C22 ssSDYWMNWV GSYYGMDYWG 3 10−5.69±0.31 10−7.53±0.07
C7 hFSDYWMNWl GSYYGMDYWG 3 10−5.53±0.18 10−5.39±0.18
C45 TFSDYWMNWV GSYdGnDYWG 3 10−5.40±0.24 & 10−5.0
C103 TFSDYWMNWV GSYYGMDlWG 3 10−5.15±0.47 10−5.44±0.55
C3 TFSDYWMsWV GSYYGMDYWG 3 & 10−5.0 & 10−5.0
C18 TFSDYsMNWV GSYYGMDYWG 3 & 10−5.0 & 10−5.0
∆ – – 12 & 10−5.0 & 10−5.0
TABLE I. Clones measured using flow cytometry
and Tite-Seq. List of scFv clones, ordered by their flow-
cytometry-measured KD values. With the exception of OPT
and ∆, these clones differed from WT only in their 1H and
3H variable regions. WT amino acids within these regions are
capitalized; variant amino acids are shown in lower case. No
sequence is shown for ∆ because this clone contained a large
deletion, making identification of the 1H and 3H variable re-
gions meaningless. KD values saturating our lower detection
limit of 10−9.5 M or upper detection limit of 10−5.0 are written
with a . or & sign to emphasize the uncertainty in these mea-
surements. Tite-Seq KD values indicate mean and standard
errors computed across the three replicate Tite-Seq experi-
ments; they are not averaged across synonymous variants.
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Name Sequence
1H library GTGTTGCCTCTGGATTCACTTTTAGTGACTACTGGATGAACTGGGTCCGCCAGTCTCCAGA
3H library GTGACTGAGGTTCCTTGACCCCAGTAGTCCATACCATAGTAAGAACCCGTACAGTAATAGATACCCAT
oRAL10 TTCTGAGGAGACGGTGACTGAGGTTCCTTG
oRAR10 TGAAGACATGGGTATCTATTACTGTACG
oRAL11 CAGTCCTTTCTCTGGAGACTGGCG
oRAR11 ATGAAACTCTCCTGTGTTGCCTCTGGATTC
3H1F TTCTGAGGAGACGGTGACT
3H2R TGAAGACATGGGTATCTATTACTGTAC
1H2F CAGTCCTTTCTCTGGAGACTG
1H1R ATGAAACTCTCCTGTGTTGCCT
oRA10 GCATATCTAAGGTCTCGTTCTGAGGAGACGGTGAC
oRA11 GCCGATTGTTGGTCTCCATGAAACTCTCCTGTGTTGC
PE1v3ext AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACG
PE2v3 AAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCT
L1AF XX ACACTCTTTCCCTACACGACGCTCTTCCGATCT[XX]AGTCTTCTTCAGAAATAAGC
L1AR XX CTCGGCATTCCTGCTGAACCGCTCTTCCGATCT[XX]GCTTGGTGCAACCTG
TABLE II. Primers. Oligonucleotide sequences are writ-
ten 5′ to 3′. Bold sequences indicate variable regions. The
“1H library” and “3H library” primers respectively contained
the 1H and 3H variable regions (bold) analyzed in this paper.
These primer libraries were synthesized by LC Biosciences us-
ing microarray-based DNA synthesis. All other primers were
ordered from Integrated DNA Technologies. The “[XX]” por-
tion of L1AF XX and L1AR XX indicates the location of each
of 64 different barcodes (i.e., XX = 01, 02, . . ., 64), which
ranged in length from 7 bp to 10 bp and which differed from
each other by at least two substitution mutations.
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FIG. S1. Cloning strategy. (A) The iRA11 amplicon library, which was prepared from microarray-synthesized oligos
containing variant CDR1H or variant CDR3H regions. This amplicon is flanked by inward-facing BsaI restriction sites. (B)
The pRA10 cloning vector, which contains the ccdB selection gene within a cassette flanked by outward-facing BsmBI restriction
sites. (C) The pRA11 plasmid library, which was cloned by ligating BsaI-digested iRA11 amplicons and BsmBI-digest pRA10
vector. (D) The sequencing amplicon that was amplified from sorted cells after Tite-Seq and Sort-Seq experiments and submitted
for ultra-high-throughput DNA sequencing. Appendix C provides more details about iRA11 amplicons, the pRA10 vector, and
the pRA11 plasmid library. Appendix D provides more information about the creation of sequencing amplicons.
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FIG. S2. Tite-Seq experiment, replicate 2. Analog
of Fig. 3 in the main text, but for the replicate 2 Tite-Seq
experiment.
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FIG. S3. Tite-Seq experiment, replicate 3. Analog
of Fig. 3 in the main text, but for the replicate 3 Tite-Seq
experiment.
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FIG. S4. Binding curves for all clones. Binding curves, measured using (A) Tite-Seq or (B) flow cytometry, for all clones
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FIG. S6. Composition of scFv libraries. (A) Comparison of library composition between all pairs of replicate experiments.
(B) Zipf plots showing the library composition in each replicate experiment. In both panels, the prevalence of each scFv sequence
in each replicate experiment was determined as part of the Tite-Seq curve fitting procedure, as described in Appendix E.
21
10−9 10−8 10−7 10−6 10−5
KD [M]
0
10−9.5
10−9.0
10−8.5
10−8.0
10−7.5
10−7.0
10−6.5
10−6.0
10−5.5
10−5.0
flu
or
es
ce
in
[M
]
replicate 1 (ρmax = 0.68)
10−9 10−8 10−7 10−6 10−5
KD [M]
replicate 2 (ρmax = 0.44)
10−9 10−8 10−7 10−6 10−5
KD [M]
replicate 2 (ρmax = 0.81)
−1
0
1
ρ
(l
og
10
K
D
,e
nr
ic
hm
en
t)
FIG. S7. Sort-Seq enrichment correlates poorly with
Tite-Seq-measured affinity. To assess how well simple en-
richment calculations might reproduce the KD values mea-
sured by Tite-Seq, we did the following calculation. For each
of the two libraries (1H and 3H), we partitioned scFvs into
seven groups based on their measured KDs (columns). For
each group at each antigen concentration (rows), we then
computed the enrichment of each scFv in the high PE bins
(bins 2,3) relative to the low PE bins (bins 0,1). In these en-
richment calculations, the number of counts in each bin was
re-weighted to accurately reflect the fraction of library cells
falling within the fluorescence range of that bin. This figure
shows the resulting Spearman rank correlation (ρ) between
enrichment and log KD values computed for each scFv group
at each antigen concentration. In both libraries, we see that
correlation values above background (which can be assessed
from the values in the 0 M fluorescein row) only occur close
to the diagonal, i.e., when KD is close to the fluorescein con-
centration used.
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FIG. S8. Different fractions of displayed OPT and
WT scFvs are functional. 2D flow cytometry histograms
showing both OPT- and WT-expressing cells labeled with PE
and BV after incubation at 2 µM fluorescein. At this fluores-
cein concentration, nearly all functional WT and OPT scFvs
are bound. Regression lines (fixed to have slope 1) were fit
to data points with BV signal between 104.5 and 105. The
vertical shift of the OPT data relative to the WT data indi-
cates a factor of 2.03 ± 0.07 difference (computed from four
replicate experiments) in the amount labeled antigen. This
difference is not due to a difference in the number of surface-
displayed scFvs, as this would cause the OPT and WT clouds
to lie along the same diagonal. Rather, this difference between
WT and OPT is due to variation in the fraction of surface-
displayed scFvs that are functional.
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FIG. S9. Realistic Tite-Seq simulations. Realistic Tite-Seq data were simulated separately for each distinct pair of affinity
(KD) and amplitude (A) values, as described in Appendix G. This figure shows simulated data, akin to the data displayed in
Fig. S8, for WT values of KD and A.
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FIG. S10. Validation of analysis pipeline. KD values were inferred for Tite-Seq data simulated using (green) the same
number of cells, (light green) 10−3 times as many cells, or (black) 104 times as many sorted cells as in our experiments. Areas
indicate approximately plus or minus one standard deviation in the fitted KD values obtained for each true KD value.
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FIG. S11. Histograms of substitution effects on affinity and expression. (A,B) Histogram showing the KD values
measured for all substitution mutations in the 1H (A) and 3H (B) libraries. Note that these are the values plotted in panels
A and B of Fig. 5, except that the WT KD value is not included. Dashed lines indicate the KD of the WT scFv; dotted lines
indicate thresholds just within our detection boundaries, 10−9.49 M and 10−5.01 M, while the colored bars outside this interval
indicate the number of substitution mutations with KD above (blue) and below (red) this range. (C,D) Histogram of E values
for all single-substitution variants in the 1H (C) or 3H (D) libraries. These values, save those of the WT scFv, are plotted in
panels C and D of Fig. 5. Dashed lines indicate the WT expression level of E = 1.0.
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FIG. S12. Effects of multi-point mutations on affinity and expression. The effect of 1, 2, or 3 mutations on (A)
Tite-Seq-measured KD values or (B) Sort-Seq-measured E values. Plots show the relative probability density (over 30 bins
along the KD or E axes) observed for variants in each class.
